NTRA vs. PPH
NTRA (Natera, Inc.) is a stock, while PPH (VanEck Pharmaceutical ETF) is Health & Biotech Equities fund tracking the MVIS US Listed Pharmaceutical 25 Index. Over the past 10 years, NTRA returned 36.51%/yr vs 8.01%/yr for PPH. Their 0.31 correlation means their historical movements had little consistent relationship.
Performance
NTRA vs. PPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NTRA achieves a 19.87% return, which is significantly higher than PPH's 7.98% return. Over the past 10 years, NTRA has outperformed PPH with an annualized return of 36.51%, while PPH has yielded a comparatively lower 8.01% annualized return.
NTRA
- 1D
- -0.21%
- 1M
- -3.23%
- 6M
- 33.56%
- YTD
- 19.87%
- 1Y
- 95.99%
- 3Y*
- 75.25%
- 5Y*
- 18.55%
- 10Y*
- 36.51%
- ALL TIME*
- 25.50%
PPH
- 1D
- 1.59%
- 1M
- -0.08%
- 6M
- 2.56%
- YTD
- 7.98%
- 1Y
- 31.41%
- 3Y*
- 13.65%
- 5Y*
- 10.09%
- 10Y*
- 8.01%
- ALL TIME*
- 5.74%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
NTRA Natera, Inc. | $291.17M | $306.89M | $352.01M |
| $37.53M | $29.64M | $28.96M |
NTRA vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NTRA Natera, Inc. | 19.87% | 44.72% | 152.71% | 55.94% | -56.99% | -6.16% | 195.40% | 141.33% | 55.28% | -23.23% |
PPH VanEck Pharmaceutical ETF | 7.98% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
Correlation
The correlation between NTRA and PPH is 0.24, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.24 |
Correlation (3Y) Balances recent behavior with more history. | 0.24 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.28 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 2015 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NTRA vs. PPH — Risk / Return Rank
NTRA
PPH
NTRA vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Natera, Inc. (NTRA) and VanEck Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NTRA | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.44 | ||
| Sortino ratioReturn per unit of downside risk | -0.08 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.31 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 3.42 | 2.93 | +0.49 |
| Martin ratioReturn relative to average drawdown | 7.70 | 7.41 | +0.29 |
Loading charts...
Drawdowns
NTRA vs. PPH - Drawdown Comparison
The maximum NTRA drawdown since its inception was -77.74%, which is greater than PPH's maximum drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for NTRA and PPH.
Loading charts...
Drawdown Indicators
| NTRA | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.74% | -51.45% | -26.29% |
Max Drawdown (1Y)Largest decline over 1 year | -28.20% | -10.76% | -17.44% |
Max Drawdown (3Y)Largest decline over 3 years | -39.94% | -18.06% | -21.88% |
Max Drawdown (5Y)Largest decline over 5 years | -77.74% | -20.26% | -57.48% |
Max Drawdown (10Y)Largest decline over 10 years | -77.74% | -29.70% | -48.04% |
Current DrawdownCurrent decline from peak | -3.23% | -3.26% | +0.03% |
Average DrawdownAverage peak-to-trough decline | -33.06% | -17.22% | -15.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.50% | 4.26% | +8.24% |
Volatility
NTRA vs. PPH - Volatility Comparison
Natera, Inc. (NTRA) has a higher volatility of 10.69% compared to VanEck Pharmaceutical ETF (PPH) at 5.82%. This indicates that NTRA's price experiences larger fluctuations and is considered to be riskier than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NTRA | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.69% | 5.82% | +4.87% |
Volatility (6M)Calculated over the trailing 6-month period | 36.90% | 13.49% | +23.41% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.79% | 17.89% | +25.90% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.01% | 15.45% | +41.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.82% | 17.07% | +43.75% |
Dividends
NTRA vs. PPH - Dividend Comparison
NTRA has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 1.98%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTRA Natera, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Pharmaceutical ETF | 1.98% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
NTRA and PPH have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NTRA has higher volatility (10.69%) compared to PPH (5.82%). In terms of maximum drawdown, NTRA dropped -77.74% vs PPH's -51.45%.
NTRA currently has the higher Sharpe Ratio (2.21 vs 1.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NTRA and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer